These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 32001325)

  • 21. Novel and emerging therapies for cholestatic liver diseases.
    Goldstein J; Levy C
    Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
    Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
    J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis.
    Kjærgaard K; Frisch K; Sørensen M; Munk OL; Hofmann AF; Horsager J; Schacht AC; Erickson M; Shapiro D; Keiding S
    J Hepatol; 2021 Jan; 74(1):58-65. PubMed ID: 32717289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
    Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
    Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
    Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
    Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
    Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis.
    van Golen RF; Olthof PB; Lionarons DA; Reiniers MJ; Alles LK; Uz Z; de Haan L; Ergin B; de Waart DR; Maas A; Verheij J; Jansen PL; Damink SWO; Schaap FG; van Gulik TM; Heger M
    Sci Rep; 2018 Nov; 8(1):16529. PubMed ID: 30409980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of Autophagy in Ageing and Chronic Cholestatic Diseases.
    Pinto C; Ninfole E; Benedetti A; Marzioni M; Maroni L
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury.
    Ren L; Song Q; Liu Y; Zhang L; Hao Z; Feng W
    Biochem Biophys Res Commun; 2019 Nov; 520(1):67-72. PubMed ID: 31575408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis.
    Akepati PR; Gochanour EM
    Expert Opin Investig Drugs; 2024 Jun; 33(6):627-638. PubMed ID: 38676426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation.
    Lu D; Liu Y; Luo Y; Zhao J; Feng C; Xue L; Xu J; Wang Q; Yan T; Xiao P; Krausz KW; Gonzalez FJ; Xie C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Feb; 1867(2):159089. PubMed ID: 34856412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
    Huang W; Qian Y; Lin J; Wang F; Kong X; Tan W
    Biochem Biophys Res Commun; 2024 Apr; 705():149670. PubMed ID: 38442444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
    Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
    Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of autophagic flux by bile acids in hepatocytes.
    Manley S; Ni HM; Kong B; Apte U; Guo G; Ding WX
    Toxicol Sci; 2014 Feb; 137(2):478-90. PubMed ID: 24189133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation.
    Weber AA; Mennillo E; Yang X; van der Schoor LWE; Jonker JW; Chen S; Tukey RH
    Drug Metab Dispos; 2021 Jan; 49(1):12-19. PubMed ID: 33154041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obeticholic acid for the treatment of primary biliary cirrhosis.
    Trivedi PJ; Hirschfield GM; Gershwin ME
    Expert Rev Clin Pharmacol; 2016; 9(1):13-26. PubMed ID: 26549695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.